Elixinol Global Limited (ASX: EXL) appoints Non-Executive Director to lead global expansion

Highlights

  • Elixinol Global Limited (ASX: EXL) has appointed retail specialist and Fellow of the Australian Institute of Company Directors, Mr Greg Ellery as Non-Executive Director.
  • Elixinol specialises in the industrial hemp, dietary supplements and emerging medicinal cannabis, all of which are rapidly moving into mainstream consumer adoption.
  • Mr Ellery’s appointment will help to establish Elixinol as the leading FCMG company in its sector.

Elixinol Global Limited (ASX: EXL) has appointed retail specialist and Fellow of the Australian Institute of Company Directors, Mr Greg Ellery as Non-Executive Director effective 12 April 2019.

Mr Ellery comes from a successful FMCG background, as CEO of the Asia Pacific region for Asahi Premium Beverages and executive positions held with Spectrum Brands, Polaroid Corporation, Fosters Group and New Balance Athletics.

Mr Ellery will utilise his established background in leading consumer packaged goods both nationally and throughout the US, Japan and Europe, to support the expanding growth of Elixinol. Elixinol specialises in the industrial hemp, dietary supplements and emerging medicinal cannabis, all of which are rapidly moving into mainstream consumer adoption. His appointment will help to establish Elixinol as the leading FCMG company in its sector.

 

About Elixinol Global (ASX: EXL)

Elixinol Global Limited (ASX: EXL; OTCQX: ELLXF) through its businesses has a global presence in the cannabis industry including hemp-derived CBD dietary supplements, hemp food and wellness products, as well as cultivation and manufacture of medicinal cannabis products.

Register Interest